Placebo Response in Depression: A Perspective for Clinical Practice.
- Published in:
- Psychopharmacology Bulletin, 2008, v. 41, n. 3, p. 91
- By:
- Publication type:
- Article
Works matching IS 00485764 AND DT 2008 AND VI 41 AND IP 3
Results: 6
1
2
Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials.
- Published in:
- Psychopharmacology Bulletin, 2008, v. 41, n. 3, p. 68
- By:
- Publication type:
- Article
3
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders.
- Published in:
- Psychopharmacology Bulletin, 2008, v. 41, n. 3, p. 39
- By:
- Publication type:
- Article
4
Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia.
- Published in:
- Psychopharmacology Bulletin, 2008, v. 41, n. 3, p. 5
- By:
- Publication type:
- Article
5
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Psychopharmacology Bulletin, 2008, v. 41, n. 3, p. 11
- By:
- Publication type:
- Article
6
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example.
- Published in:
- Psychopharmacology Bulletin, 2008, v. 41, n. 3, p. 1
- By:
- Publication type:
- Article